Research archive

Robert J. Alpern, M.D.

Robert J. Alpern, M.D., Ensign Professor of Medicine and Physiology and Former Dean of Yale School of Medicine at AbbVie Inc.. Biography, career history and compensation sourced from SEC proxy filings.

About

Robert J. Alpern, M.D., is the Ensign Professor of Medicine and Physiology and Former Dean of the Yale School of Medicine, contributing deep scientific and health-care expertise to AbbVie's board since 2013. He has served on the Nominations & Governance and Public Policy & Sustainability committees. Consistent with AbbVie's governance guidelines, Dr. Alpern, having reached age 75, will not stand for re-election at the 2026 annual stockholder meeting, reducing the board to twelve directors.

Roles

AbbVie Inc.

Ensign Professor of Medicine and Physiology and Former Dean of Yale School of Medicine · Current role

2013–present

Yale School of Medicine

Dean · Former Dean; currently Ensign Professor of Medicine and Physiology

—

Director Compensation

FY 2025

Fees Earned or Paid in Cash

$122,917

Restricted Stock Unit Awards

$224,961

Also at AbbVie Inc.

Robert A. Michael

Chairman of the Board and Chief Executive Officer

Roxanne S. Austin

Lead Independent Director; President, Austin Investment Advisors

William H.L. Burnside

Retired Senior Vice President and Director, The Boston Consulting Group

Related

Abbvie Aliada Therapeutics 2024

Abbvie Allergan 2020

See how Top Bucket AI works for your firm

Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.

Dated reference snapshot as of September 10, 2026. This is not a live financial feed. Verify figures against primary filings before relying on them.